For Rare Disease Biotechs

For rare disease biotechs at a commercial inflection point.

When the science is ready and the commercial picture is still forming, the positioning you set now shapes everything that follows.

The moments we step into.

Scenario 01

In early-stage development.

The scientific story is still building, the insights are accumulating, but you are far from having a formalized narrative. However you need to effectively communicate with your patient community, have a presence at congresses, engage your KOL stakeholders. Compleo Advisors can craft your early positioning and communication platform, and create needed activations, that will ensure you are consistent, on-strategy and maximizing each stakeholder touchpoint.

Scenario 02

Building advocacy engagement that holds.

Advocacy relationships are forming, and the engagement strategy needs to catch up. Compleo Advisors builds an intentional advocacy approach: which organizations to engage, how to engage them as equals, and what partnership models drive real outcomes.

Scenario 03

Show up with character at the next patient meeting.

You are in human trials. You are going to a congress or patient meeting where the community, advocacy partners, investigators, and KOLs are there. So are the competition. How will you present your company and communicate your positioning, your value? Will your stakeholders leave thinking what you want, and seeing you as a partner? Compleo Advisors will work with you, and your limited resources, to create experiences that surprise and reinforce your positioning.

Scenario 04

Preparing for commercial scale.

The organization is moving from clinical to commercial, and the commercial building blocks need to come together fast, even though you still have a limited commercial budget. Compleo Advisors helps ensure your critical building blocks, from strategy, positioning, and narrative to time-sensitive efforts like market shaping and patient engagement, are in place now. Then when it's time to bring in the big agency we'll perform a clean hand-off, ensuring no loss of knowledge or momentum. We'll even help with your agency selection.

The outcome

What changes.

Positioning becomes precise.

The story you tell about your asset and your company is built from deep stakeholder insight. It earns credibility with the people who actually shape the market.

Advocacy engagement becomes strategy.

Relationships with advocacy communities are designed with intent, structured for mutual value, and grounded in respect for what advocacy organizations bring.

Strategy becomes activation.

The thinking does not stop at slideware. Compleo Advisors carries strategy through to creative execution, market presence, and the partnerships that move the field.

Services

What we do for biotechs.

Strategy and execution that move together, sequenced to where you are.

Strategic services

  • Stakeholder insight, market research, and competitive analysis
  • Brand positioning and patient journey mapping
  • Advocacy landscaping and engagement strategy
  • Social media and ecosystem analyses
  • Facilitated advocacy partnerships, patient meetings, and family events

Tactical and creative services

  • Market shaping and disease education campaigns
  • Messaging development (scientific, disease education, commercial)
  • Medical congress experiences
  • Patient videos, family-day programs, and educational materials
  • Digital assets and social media editorial planning
  • Media, PR, and analytics partnerships for full execution

Proof

The work, in practice.

Selected engagements from inside rare disease commercialization. Client identities held to protect confidentiality.

Blinded Case · Launch Readiness

Building a patient experience function ahead of launch.

An early-stage rare disease biotech approaching its first commercial launch needed an internal patient experience capability that could move quickly. Compleo Advisors built the internal communications and training program, drawing on social media insights and patient stories to ground the work in real community voice.

Full case study available on request.

Blinded Case · Patient Insight

Long-term social listening for an ultra-rare community.

A small, very early-stage biotech in an ultra-rare disease needed to understand unmet patient need without disrupting a small and protective community. Compleo Advisors designed and executed a long-term social listening program that surfaced the insights leadership needed for strategic decisions.

Full case study available on request.

Building toward a commercial inflection point? Let's talk.

Start a conversation → See how we work →